FDA approves treatment for Rare form of Batten disease
admin 2nd May 2017 Uncategorised 0Pharmacy Times
More: FDA approves treatment for Rare form of Batten disease
Source: MDlinx
Pharmacy Times
More: FDA approves treatment for Rare form of Batten disease
Source: MDlinx
Data favor Merck, Eisai’s Keytruda-Lenvima as the winner in kidney cancer, but window still open for Bristol Myers: analyst
Data favor Merck, Eisai’s Keytruda-Lenvima as the winner in kidney
FDA could reject AstraZeneca’s COVID vaccine on efficacy and manufacturing shortfalls: analyst
FDA could reject AstraZeneca’s COVID vaccine on efficacy and manufa
Pfizer, Moderna pledge more mRNA vaccine doses to Europe after AZ supply concerns
Pfizer, Moderna pledge more mRNA vaccine doses to Europe after AZ sup
| M | T | W | T | F | S | S |
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | 6 | 7 |
| 8 | 9 | 10 | 11 | 12 | 13 | 14 |
| 15 | 16 | 17 | 18 | 19 | 20 | 21 |
| 22 | 23 | 24 | 25 | 26 | 27 | 28 |
| 29 | 30 | 31 | ||||
© 1994 - 2021 B.M. Pharmaceuticals